Hide Board Information

Show Board Information

Artistmss International Group, Inc. AIGI

Board Mod: vulken17

Asst Mods:

Last Post: 03/05/2014 8:10:41 PM

Board Marks: 20

Posts Today: 0

Board Views Today: 55

Artistmss International Group, Inc. (OTCMRKTS: AIGI) Stock Message Board

1. AIGI Company Profile

    

2. AIGI Time & Sales

    

3. AIGI Recent News

    

4. AIGI Filings

    

5. AIGI Financials

    

6. AIGI Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	AGIJ Golden Cross WOW. just noticed.	vulken17	05/01/2012 1:57:40 PM
7	http://www.obj.ca/Local/2011-02-03/article-219529	vulken17	05/01/2012 1:17:05 PM
6	AGIJ. Collagenna merger with OTCBB Company. We	vulken17	05/01/2012 9:59:19 AM
5	http://www.minamargroup.net/support/index.php?_m=	vulken17	04/25/2012 11:39:42 AM
4	AGIJ http://www.collagenna.ca/	vulken17	04/25/2012 11:38:03 AM
3	$AGIJ Collagenna (AGIJ) Private Label European	vulken17	04/23/2012 1:59:01 PM
2	AGIJ 300-400 million shares retired. 900 million	vulken17	04/21/2012 4:44:30 PM
1	http://bit.ly/IMplRu AGIJ Merger / Buy	vulken17	04/19/2012 2:00:51 PM

Newer

Recent Articles

• Bioventus Inc. Reports Q1 Financial Results and Guidance
• Peabody's Q1 Performance Highlights: Key Financial Metrics
• Zevra Therapeutics Announces Q1 2025 Financial Results Schedule
• Genie Energy Reports Strong Q1 2025 Financial Performance
• Explore The Future of Smart Home Technology at Canton Fair
• Caliber Partners with Hyatt for New Hotel Developments Across U.S.
• Stardust Power to Report Q1 2025 Financial Results Soon
• Sensei Biotherapeutics Insights on Q1 2025 Results and Progress
• Kura Oncology's Exciting Participation at Healthcare Conference 2025
• CorMedix Inc. Showcases Strong Financial Growth in Q1 2025
• Anavex Life Sciences Prepares to Share Q2 Financial Insights
• OnKure Therapeutics Unveils Financial Progress and Key Updates
• Altimmune's Upcoming Financial Results Announcement for 2025
• Highlights from Amerigo Resources Ltd.'s Annual Meeting Results
• FTI Consulting Welcomes Veteran Leader to Energy Division
• Pony AI and Uber Form Alliance to Revolutionize Mobility
• Jeffs’ Brands Announces Significant Strategic Transactions
• Caledonia Mining Corporation’s AGM Outcome: Key Insights
• Niall Prendiville Takes CPO Role at CSafe to Boost Innovation
• Key Insights on Alpha Group International's Investor Disclosure
• Ballard Power Systems Shows Growth in Recent Financial Metrics
• Sunstone Hotel Investors Shines in Latest Financial Report
• Leadership Transition at TransDigm: New CEO Announcement
• Impressive Growth: MSG Entertainment's Active Third Quarter Reveal
• Heron Therapeutics and Mylan Reach Settlement on Key Patents
• Factor Bioscience Unveils Innovations in Gene Editing Techniques
• Bloomberg Enhances IBVAL for Broader Emerging Market Bond Coverage
• Transformative Financing Agreement to Propel SolarBank's Growth
• Galmed's Innovative Research: Aramchol and Regorafenib Synergy
• Valour Reports Record Growth and Expands ETP Offerings
• Revolutionizing Opioid Addiction Treatment for Better Outcomes
• Leadership Transition at TransDigm: Mike Lisman Takes Reins
• AMETEK's Move to Acquire FARO Technologies: An Exciting Future
• Lakeside Hire Triumphs with Feefo Award for Customer Excellence
• Exciting Product Innovations from TCL SunPower Global Revealed
• Unveiling the 7-Eleven Gold Pass: Perks for Every Taste
• TCL SunPower Global Launches Innovative Green Solutions
• Battalion Brands Welcomes Andy Stofleth as Strategic Leader
• Mill Creek Residential Launches Preleasing for Modera Liberty Row
• TransDigm Group Shows Robust Growth in Q2 Fiscal 2025 Report
• Lithium Ionic Enhances Resource Estimate at Bandeira Project
• TransDigm Group's Strong Fiscal Performance in Q2 2025
• Sitryx Advances SIT-047 for Clinical Trials in Arthritis Market
• EnteroBiotix Shares Promising Results on Gut Health Therapy
• Optima Health Expands Services with Care First Acquisition
• Strategic Alliance to Enhance Road Safety Solutions in LATAM
• Embraer's Strong Financials in Q1 2025 Results Announcement
• Signify Updates Share Repurchase Program Details
• Breakthrough Results for TPM502 in Celiac Disease Treatment
• Vantage Hemp Co. Expands Horizons with Brazil Market Entry Plans